Covalon Technologies EBITDA 2013-2024 | CVALF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Covalon Technologies ebitda from 2013 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Covalon Technologies ebitda from 2013 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$234.6B
Intuitive Surgical (ISRG)	$174.6B
Alcon (ALC)	$48.6B
IQVIA Holdings (IQV)	$43.6B
IDEXX Laboratories (IDXX)	$42.1B
Edwards Lifesciences (EW)	$41.8B
DexCom (DXCM)	$28.1B
STERIS (STE)	$24B
SONOVA HOLDING (SONVY)	$21.5B
Waters (WAT)	$19.5B
Hologic (HOLX)	$19.2B
Sysmex ADR (SSMXY)	$12.3B
Fresenius Medical Care AG KGaA (FMS)	$12.3B
Teleflex (TFX)	$11.6B
Globus Medical (GMED)	$9.5B
Penumbra (PEN)	$7.3B
Glaukos (GKOS)	$6.8B
Masimo (MASI)	$6.1B
TransMedics (TMDX)	$5B
Integer Holdings (ITGR)	$4.3B
PROCEPT BioRobotics (PRCT)	$4.3B
Tandem Diabetes Care (TNDM)	$2.8B
Inari Medical (NARI)	$2.7B
LivaNova (LIVN)	$2.6B
Nihon Kohden (NHNKY)	$2.6B
Veracyte (VCYT)	$2.6B
Elekta AB (EKTAY)	$2.4B
RxSight (RXST)	$2.1B
Integra LifeSciences Holdings (IART)	$1.3B
Pulse Biosciences (PLSE)	$1.2B